Limitations of the current study include the lack of data regarding the regulatory mechanism of SPP1 and/or HMOX1 in glioma cell growth, as well as not providing in‐depth profiling for SPP1 and/or HMOX1 in different histologic grades of LGG or GBM. The gene discussed is SPP1; the disease is central nervous system cancer.